Ben O’Leary

4.2k citations
37 papers · 2.7k indexed · 4 hit papers · h-index 14
Topics
Cancer Genomics and Diagnostics (14 papers)Advanced Breast Cancer Therapies (13 papers)Lung Cancer Research Studies (8 papers)

In The Last Decade

Ben O’Leary

33 papers receiving 2.6k citations

Hit Papers

Treating cancer with selective CDK4/6 inhibitors20162026201920222016201620182022250500750

Peers

Ben O’Leary
Comparison fields: 5 of 79
  • Oncology 1.7k
  • Pulmonary and Respiratory Medicine 1.7k
  • Cancer Research 1.3k
  • Molecular Biology 810
  • Genetics 341
Replace Gábor Rubovszky with:
Gábor Rubovszky Hungary
Eva Ciruelos Spain
Maya Gutierrez France
Florence Lerebours France
Katarína Petráková Czechia
Kevin Kalinsky United States
Jeremy Hoog United States
James R. Vasselli United States
Seth A. Wander United States
Yuqiu Jiang United States
Ben O’Leary relative to Gábor Rubovszky Hungary Gábor Rubovszky's profile →
Citations per field
00.5×6.1×
Gábor Rubovszky · 1×
Citations per year

Countries citing papers authored by Ben O’Leary

Since Specialization
Citations

This map shows the geographic impact of Ben O’Leary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben O’Leary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben O’Leary more than expected).

Fields of papers citing papers by Ben O’Leary

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben O’Leary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben O’Leary. The network helps show where Ben O’Leary may publish in the future.

Co-authorship network of co-authors of Ben O’Leary

This figure shows the co-authorship network connecting the top 25 collaborators of Ben O’Leary. A scholar is included among the top collaborators of Ben O’Leary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben O’Leary. Ben O’Leary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 10
4 2
5 0
6 7
7 4
8 11
9
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2− ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Studybreakdown →
114
10 65
11 71
12
The Genetic Landscape and Clonal Evolution of Breast Cancer Resistance to Palbociclib plus Fulvestrant in the PALOMA-3 Trialbreakdown →
401
13 293
14 118
15 27
16 7
17
Treating cancer with selective CDK4/6 inhibitorsbreakdown →
790
18 1
19 1
20 11

About Ben O’Leary

Ben O’Leary is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 37 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (14 papers), Advanced Breast Cancer Therapies (13 papers) and Lung Cancer Research Studies (8 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.7k citations) and Pulmonary and Respiratory Medicine (1.7k citations). Ben O’Leary has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Nicholas C. Turner, Richard S. Finn, Isaac García-Murillas, Sarah Hrebien, Massimo Cristofanilli, Cynthia Huang Bartlett, Sherene Loi, Fabrice André, Sibylle Loibl and Matthew Beaney. Their work appears in journals such as JAMA, Nature Communications and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026